Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Blocking DKK1 with siRNA can improve hair growth.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Raspberry ketone may help grow hair and improve skin elasticity.

Using special RNA to target a mutant gene fixed hair problems in mice.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

Finasteride may help reduce COVID-19 infection by altering a key gene.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Platelet-rich plasma improves bladder function and reduces overactivity in ketamine-induced bladder issues.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.